Close Menu

NEW YORK ─ Luminex on Tuesday announced preliminary fourth quarter revenue growth of approximately 23 percent year over year.

For the quarter ended Dec. 31, 2020, the Austin, Texas-based diagnostics company expects to report revenues of approximately $111 million, compared to $90.5 million in Q4 2019, which would beat analysts' average estimate for revenues of $104.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.